
Loading page…
The Urine Glucose Postprandial (2-Hour) test detects the presence of glucose in urine collected exactly 2 hours after a meal. Under normal conditions, healthy kidneys reabsorb all filtered glucose and none appears in urine. When blood glucose exceeds the renal reabsorptive threshold (approximately 180 mg/dL), glucose 'spills' into urine (glycosuria). Post-meal urine glucose is most commonly ordered alongside a Postprandial Blood Sugar (PPBS) test to provide a combined blood-and-urine picture of post-meal glucose handling. No fasting required. Timing is critical — urine must be collected at the 2-hour mark after eating.
Key benefits of this package include:
What Does the Urine Glucose — Postprandial (2-Hour) Test Measure?
| Level / Result | Possible Interpretation |
|---|---|
| Negative (Normal) | No glucose in urine — blood glucose did not exceed renal threshold (~180 mg/dL) post-meal |
| Trace / 1+ Positive | Low-level glucosuria — post-meal blood glucose likely 180–250 mg/dL; confirm with PPBS |
| 2+ / 3+ / 4+ Positive | Significant glucosuria — post-meal blood glucose likely > 250–300 mg/dL; significant hyperglycaemia; clinical review required |
| Positive urine glucose + Normal PPBS | Renal glycosuria — low renal threshold; benign condition or SGLT2 inhibitor effect; not diabetes-related |
| Positive urine glucose + Elevated PPBS (> 200 mg/dL) | Diabetic glycosuria — post-meal blood glucose exceeds renal threshold confirming significant hyperglycaemia |
Important Note: Urine glucose is a qualitative/semi-quantitative screening test — it does not give an exact blood glucose value and cannot replace blood glucose measurement for diabetes diagnosis or management decisions. Glycosuria with a normal blood glucose indicates renal glycosuria (benign low renal threshold). The absence of urine glucose does not exclude hyperglycaemia below ~180 mg/dL. All results must be reviewed by a physician.
SGLT2 Inhibitors and Urine Glucose — A Therapeutic Glycosuria: SGLT2 (Sodium-Glucose Cotransporter 2) inhibitors — including empagliflozin, dapagliflozin, and canagliflozin — are modern diabetes medications that intentionally block glucose reabsorption in the kidney, causing persistent glycosuria as their mechanism of action. Patients on these drugs will have positive urine glucose even when blood sugar is well-controlled. This is expected and therapeutic — not a sign of poor diabetes control. A positive urine glucose in a patient on an SGLT2 inhibitor simply confirms the drug is working as intended.

Book once, we handle the rest. Our certified phlebotomist arrives at your doorstep — your report is delivered within 24 hours.
Trusted by millions of Customers across South India — these are the tests our doctors recommend most.